These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2402187

  • 1. Elevated levels of serum dolichol in aspartylglucosaminuria.
    Salaspuro M, Salmela K, Humaloja K, Autio S, Arvio M, Palo J.
    Life Sci; 1990; 47(7):627-32. PubMed ID: 2402187
    [Abstract] [Full Text] [Related]

  • 2. Blood dolichol in lysosomal diseases.
    Jokelainen K, Salmela KS, Humaloja K, Roine R, Autio S, Arvio M, Järvelä I, Nykänen I, Palo J, Salaspuro M.
    Biochem Cell Biol; 1992 Jun; 70(6):481-5. PubMed ID: 1449714
    [Abstract] [Full Text] [Related]

  • 3. Serum dolichols in different clinical conditions.
    Humaloja K, Roine RP, Salmela K, Halmesmäki E, Jokelainen K, Salaspuro M.
    Scand J Clin Lab Invest; 1991 Dec; 51(8):705-9. PubMed ID: 1806986
    [Abstract] [Full Text] [Related]

  • 4. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes.
    Näntö-Salonen K, Halme T, Penttinen R, Langevelde FV, Vis RD, Alfthan G.
    J Inherit Metab Dis; 1985 Dec; 8(4):212-8. PubMed ID: 3939546
    [Abstract] [Full Text] [Related]

  • 5. Effects of Triton WR 1339 and orotic acid on biliary and serum dolichols in rats.
    Humaloja K, Roine RP, Salaspuro M.
    Metabolism; 1998 Jun; 47(6):644-9. PubMed ID: 9627360
    [Abstract] [Full Text] [Related]

  • 6. Serum dolichols in chronic cholestatic liver diseases.
    Humaloja K, Roine RP, Vuoristo M, Färkkilä M, Höckerstedt K, Salaspuro M.
    J Hepatol; 1999 Dec; 31(6):1014-9. PubMed ID: 10604574
    [Abstract] [Full Text] [Related]

  • 7. Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.
    Lindblom N, Kivinen S, Heiskala H, Laakso ML, Kaski M.
    J Inherit Metab Dis; 2006 Oct; 29(5):637-46. PubMed ID: 16944277
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of collagen in aspartylglycosaminuria: urinary excretion of hydroxyproline.
    Näntö-Salonen K, Autio S, Härö E, Kivimäki T, Koskela SL, Näntö V, Penttinen R.
    J Inherit Metab Dis; 1984 Oct; 7(3):117-21. PubMed ID: 6438393
    [Abstract] [Full Text] [Related]

  • 9. Detection of aspartylglycosaminuria by gas--liquid chromatography.
    Maury CP.
    Clin Chem; 1981 Dec; 27(12):2058-60. PubMed ID: 7307258
    [Abstract] [Full Text] [Related]

  • 10. Prenatal diagnosis and fetal pathology of aspartylglucosaminuria.
    Aula P, Rapola J, von Koskull H, Ammälä P.
    Am J Med Genet; 1984 Oct; 19(2):359-67. PubMed ID: 6507482
    [Abstract] [Full Text] [Related]

  • 11. Effect of alcohol on blood dolichol concentration.
    Roine RP, Nykänen I, Ylikahri R, Heikkilä J, Suokas A, Salaspuro M.
    Alcohol Clin Exp Res; 1989 Aug; 13(4):519-22. PubMed ID: 2679208
    [Abstract] [Full Text] [Related]

  • 12. Urinary glycosaminoglycans in aspartylglycosaminuria: evidence for disturbed proteoglycan metabolism.
    Näntö-Salonen K, Larjava H, Aalto M, Kivimäki T.
    Clin Chim Acta; 1985 Mar 15; 146(2-3):111-8. PubMed ID: 3987044
    [Abstract] [Full Text] [Related]

  • 13. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E, Peltonen L.
    Hum Mutat; 1992 Mar 15; 1(5):361-5. PubMed ID: 1301945
    [Abstract] [Full Text] [Related]

  • 14. N-Acetylglucosamine-asparagine levels in tissues of patients with aspartylglycosaminuria.
    Maury CP, Palo J.
    Clin Chim Acta; 1980 Dec 08; 108(2):293-9. PubMed ID: 7449147
    [Abstract] [Full Text] [Related]

  • 15. Aspartylglucosaminuria among Palestinian Arabs.
    Zlotogora J, Ben-Neriah Z, Abu-Libdeh BY, Sury V, Zeigler M.
    J Inherit Metab Dis; 1997 Nov 08; 20(6):799-802. PubMed ID: 9427148
    [Abstract] [Full Text] [Related]

  • 16. Aspartylglycosaminuria: an inborn error of glycoprotein catabolism.
    Maury CP.
    J Inherit Metab Dis; 1982 Nov 08; 5(4):192-6. PubMed ID: 6820440
    [Abstract] [Full Text] [Related]

  • 17. Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.
    Arvio P, Arvio M, Kero M, Pirinen S, Lukinmaa PL.
    J Med Genet; 1999 May 08; 36(5):398-404. PubMed ID: 10353787
    [Abstract] [Full Text] [Related]

  • 18. Liquid-chromatographic detection of aspartylglycosaminuria.
    Mononen T, Parviainen M, Penttilä I, Mononen I.
    Clin Chem; 1986 Mar 08; 32(3):501-2. PubMed ID: 3948393
    [Abstract] [Full Text] [Related]

  • 19. Aspartylglycosaminuria in an Italian family: clinical and biochemical characteristics.
    Gehler J, Sewell AC, Becker C, Spranger J, Hartmann J.
    J Inherit Metab Dis; 1981 Mar 08; 4(4):229-30. PubMed ID: 6796777
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast expression of collagens and proteoglycans is altered in aspartylglucosaminuria, a lysosomal storage disease.
    Määttä A, Järveläinen HT, Nelimarkka LO, Penttinen RP.
    Biochim Biophys Acta; 1994 Feb 22; 1225(3):264-70. PubMed ID: 8312372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.